Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1997 Jan;52(1):17–21. doi: 10.1136/thx.52.1.17

Impact of management guidelines on the outcome of severe community acquired pneumonia

N A Hirani, J T Macfarlane
PMCID: PMC1758402  PMID: 9039234

Abstract

BACKGROUND: Ten years ago we published a study of 50 adults with severe community acquired pneumonia admitted to our intensive care unit and subsequently introduced guidelines for the management of severe community acquired pneumonia which are largely in accordance with those of the British Thoracic Society. The results of a follow up study are now reported in order to assess their impact on the outcome of this disease. METHODS: Fifty seven cases of severe community acquired pneumonia admitted to our ICU between 1984 and 1993 were studied. Causal pathogens, clinical and laboratory features of severity, antibiotic therapy and mortality were studied and, where possible, compared with results from the previous study. RESULTS: Streptococcus pneumoniae, Legionella pneumophila and Staphylococcus aureus were the most frequent causes of severe community acquired pneumonia, as in the previous study. The intensity of microbial investigation has increased, particularly with regard to pneumococcal and Legionella antigen testing, the latter allowing earlier diagnosis of Legionella infection than previously. In spite of this, no pathogen was identified in 33% of cases compared with 18% previously. Indices of severity of illness were widely recognised, and a decrease in unplanned transfers to the ICU following "unexpected" cardiorespiratory arrest from 25% to 7% (p < 0.02) was found. Antibiotic therapy largely reflected guideline recommendations with 98% receiving a beta-lactam agent and 91% erythromycin. The overall mortality was 58% compared with 54% previously. CONCLUSIONS: Management guidelines for severe community acquired pneumonia have been widely adopted but without a reduction in mortality in our hospital. Factors other than early diagnosis, appropriate antibiotics, or prompt ICU transfer may influence the outcome in severe community acquired pneumonia. 




Full Text

The Full Text of this article is available as a PDF (110.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almirall J., Mesalles E., Klamburg J., Parra O., Agudo A. Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest. 1995 Feb;107(2):511–516. doi: 10.1378/chest.107.2.511. [DOI] [PubMed] [Google Scholar]
  2. Andrews C. P., Coalson J. J., Smith J. D., Johanson W. G., Jr Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest. 1981 Sep;80(3):254–258. doi: 10.1378/chest.80.3.254. [DOI] [PubMed] [Google Scholar]
  3. El-Refaie M., Tait R., Dulake C., Dische F. E. Pneumococcal antigen in pneumonia. A post-mortem study with the histological and bacteriological findings. Postgrad Med J. 1976 Aug;52(610):497–500. doi: 10.1136/pgmj.52.610.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Farr B. M., Sloman A. J., Fisch M. J. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med. 1991 Sep 15;115(6):428–436. doi: 10.7326/0003-4819-115-6-428. [DOI] [PubMed] [Google Scholar]
  5. Fedullo A. J., Swinburne A. J. Relationship of patient age to clinical features and outcome for in-hospital treatment of pneumonia. J Gerontol. 1985 Jan;40(1):29–33. doi: 10.1093/geronj/40.1.29. [DOI] [PubMed] [Google Scholar]
  6. Fein A. M., Niederman M. S. Guidelines for the initial management of community-acquired pneumonia: savory recipe or cookbook for disaster? Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1149–1153. doi: 10.1164/ajrccm.152.4.7551362. [DOI] [PubMed] [Google Scholar]
  7. Feldman C., Kallenbach J. M., Levy H., Reinach S. G., Hurwitz M. D., Thorburn J. R., Koornhof H. J. Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a "severity of illness" core. Intensive Care Med. 1989;15(5):302–307. doi: 10.1007/BF00263865. [DOI] [PubMed] [Google Scholar]
  8. Harrison T. G., Taylor A. G. Diagnosis of Legionella pneumophila infections by means of formolised yolk sac antigens. J Clin Pathol. 1982 Feb;35(2):211–214. doi: 10.1136/jcp.35.2.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hook E. W., 3rd, Horton C. A., Schaberg D. R. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA. 1983 Feb 25;249(8):1055–1057. [PubMed] [Google Scholar]
  10. Hurwitz B. Clinical guidelines: proliferation and medicolegal significance. Qual Health Care. 1994 Mar;3(1):37–44. doi: 10.1136/qshc.3.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kaye M. G., Fox M. J., Bartlett J. G., Braman S. S., Glassroth J. The clinical spectrum of Staphylococcus aureus pulmonary infection. Chest. 1990 Apr;97(4):788–792. doi: 10.1378/chest.97.4.788. [DOI] [PubMed] [Google Scholar]
  12. Moine P., Vercken J. B., Chevret S., Chastang C., Gajdos P. Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit. Chest. 1994 May;105(5):1487–1495. doi: 10.1378/chest.105.5.1487. [DOI] [PubMed] [Google Scholar]
  13. Pachon J., Prados M. D., Capote F., Cuello J. A., Garnacho J., Verano A. Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis. 1990 Aug;142(2):369–373. doi: 10.1164/ajrccm/142.2.369. [DOI] [PubMed] [Google Scholar]
  14. Rello J., Ausina V., Ricart M., Castella J., Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest. 1993 Oct;104(4):1230–1235. doi: 10.1378/chest.104.4.1230. [DOI] [PubMed] [Google Scholar]
  15. Rodgers F. G. Identification of Legionella pneumophila antigens and antibodies by immunoferritin electron microscopy. J Med Microbiol. 1982 May;15(2):181–187. doi: 10.1099/00222615-15-2-181. [DOI] [PubMed] [Google Scholar]
  16. Sathapatayavongs B., Kohler R. B., Wheat L. J., White A., Winn W. C., Jr, Girod J. C., Edelstein P. H. Rapid diagnosis of Legionnaires' disease by urinary antigen detection. Comparison of ELISA and radioimmunoassay. Am J Med. 1982 Apr;72(4):576–582. doi: 10.1016/0002-9343(82)90451-x. [DOI] [PubMed] [Google Scholar]
  17. Sörensen J., Forsberg P., Håkanson E., Maller R., Sederholm C., Sörén L., Carlsson C. A new diagnostic approach to the patient with severe pneumonia. Scand J Infect Dis. 1989;21(1):33–41. doi: 10.3109/00365548909035678. [DOI] [PubMed] [Google Scholar]
  18. Torres A., Serra-Batlles J., Ferrer A., Jiménez P., Celis R., Cobo E., Rodriguez-Roisin R. Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis. 1991 Aug;144(2):312–318. doi: 10.1164/ajrccm/144.2.312. [DOI] [PubMed] [Google Scholar]
  19. Tunis S. R., Hayward R. S., Wilson M. C., Rubin H. R., Bass E. B., Johnston M., Steinberg E. P. Internists' attitudes about clinical practice guidelines. Ann Intern Med. 1994 Jun 1;120(11):956–963. doi: 10.7326/0003-4819-120-11-199406010-00008. [DOI] [PubMed] [Google Scholar]
  20. Watanakunakorn C. Bacteremic Staphylococcus aureus pneumonia. Scand J Infect Dis. 1987;19(6):623–627. doi: 10.3109/00365548709117196. [DOI] [PubMed] [Google Scholar]
  21. Woodhead M. A., Macfarlane J. T., Macrae A. D., Pugh S. F. The rise and fall of Legionnaires' disease in Nottingham. J Infect. 1986 Nov;13(3):293–296. doi: 10.1016/s0163-4453(86)91421-0. [DOI] [PubMed] [Google Scholar]
  22. Woodhead M. A., Macfarlane J. T., McCracken J. S., Rose D. H., Finch R. G. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet. 1987 Mar 21;1(8534):671–674. doi: 10.1016/s0140-6736(87)90430-2. [DOI] [PubMed] [Google Scholar]
  23. Woodhead M. A., Macfarlane J. T., Rodgers F. G., Laverick A., Pilkington R., Macrae A. D. Aetiology and outcome of severe community-acquired pneumonia. J Infect. 1985 May;10(3):204–210. doi: 10.1016/s0163-4453(85)92463-6. [DOI] [PubMed] [Google Scholar]
  24. Woodhead M. A., Radvan J., Macfarlane J. T. Adult community-acquired staphylococcal pneumonia in the antibiotic era: a review of 61 cases. Q J Med. 1987 Sep;64(245):783–790. [PubMed] [Google Scholar]
  25. van Eeden S. F., Coetzee A. R., Joubert J. R. Community-acquired pneumonia--factors influencing intensive care admission. S Afr Med J. 1988 Jan 23;73(2):77–81. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES